HomeCompareADNPX vs JNJ

ADNPX vs JNJ: Dividend Comparison 2026

ADNPX yields 11.73% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADNPX wins by $23.3K in total portfolio value
10 years
ADNPX
ADNPX
● Live price
11.73%
Share price
$17.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.4K
Annual income
$2,440.68
Full ADNPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ADNPX vs JNJ

📍 ADNPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADNPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADNPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADNPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADNPX
Annual income on $10K today (after 15% tax)
$997.07/yr
After 10yr DRIP, annual income (after tax)
$2,074.58/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ADNPX beats the other by $1,370.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADNPX + JNJ for your $10,000?

ADNPX: 50%JNJ: 50%
100% JNJ50/50100% ADNPX
Portfolio after 10yr
$31.7K
Annual income
$1,634.23/yr
Blended yield
5.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ADNPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADNPX buys
0
JNJ buys
0
No recent congressional trades found for ADNPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADNPXJNJ
Forward yield11.73%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$43.4K$20.0K
Annual income after 10y$2,440.68$827.78
Total dividends collected$17.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ADNPX vs JNJ ($10,000, DRIP)

YearADNPX PortfolioADNPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,873$1,173.02$10,676$355.77+$1.2KADNPX
2$14,006$1,301.62$11,407$389.39+$2.6KADNPX
3$16,421$1,434.98$12,198$426.53+$4.2KADNPX
4$19,143$1,572.38$13,056$467.62+$6.1KADNPX
5$22,196$1,713.09$13,987$513.12+$8.2KADNPX
6$25,606$1,856.36$14,998$563.56+$10.6KADNPX
7$29,400$2,001.46$16,098$619.52+$13.3KADNPX
8$33,606$2,147.67$17,295$681.69+$16.3KADNPX
9$38,252$2,294.29$18,599$750.82+$19.7KADNPX
10$43,371$2,440.68$20,022$827.78+$23.3KADNPX

ADNPX vs JNJ: Complete Analysis 2026

ADNPXStock

Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are in both developed and emerging markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.

Full ADNPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ADNPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADNPX vs SCHDADNPX vs JEPIADNPX vs OADNPX vs KOADNPX vs MAINADNPX vs ABBVADNPX vs MRKADNPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.